Premium
Soleno Therapeutics Inc (SLNO)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.07 | 0.156564526951 | 44.71 | 49.795 | 43.4 | 726116 | 45.85956887 | CS |
| 4 | -6.23 | -12.2132915115 | 51.01 | 52.46 | 43.06 | 482159 | 47.03500075 | CS |
| 12 | -1.93 | -4.13187754228 | 46.71 | 52.46 | 41.5 | 507322 | 46.77256117 | CS |
| 26 | -4.18 | -8.53758169935 | 48.96 | 60.92 | 41.5 | 589308 | 50.45536568 | CS |
| 52 | 1.78 | 4.13953488372 | 43 | 60.92 | 36.61 | 522090 | 47.86835015 | CS |
| 156 | 44.4604 | 13911.2640801 | 0.3196 | 60.92 | 0.1302 | 729600 | 16.92379237 | CS |
| 260 | 41.84 | 1423.1292517 | 2.94 | 60.92 | 0.1302 | 811084 | 9.7786465 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
